A Phase 3b/4 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants with Alzheimer's Disease

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Brain Imaging Center (BIC)
CU-RIC
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Photograph of Victoria Pelak,  MD

Victoria Pelak, MD

Study ID

Protocol Number: 22-0776

More information available at ClinicalTrials.gov: NCT05310071

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers